The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Dr Ashraf Azzabi graduated in 1992 and joined the Northern Centre for Cancer Care in 1997 as a registrar in medical oncology and completed a research degree in early drug development at Newcastle University. He treats testicular, urological and colorectal cancers in Newcastle, Sunderland and South Tyneside.
Dr Ashraf Azzabi is actively involved, as a principal investigator, in a number of national and international clinical trials both in urological and colorectal cancers. He chaired the systemic therapies group at the cancer centre, the north east of England colorectal cancer tumour specific group. He also currently leads the late phase cancer research team at the northern centre for cancer care and has a role as the NIHR cancer research lead for the Newcastle upon Tyne hospitals NHS foundation Trust and, holds a role as the regional clinical lead for cancer research at the NIHR North east and North Cumbria research network.
Northern Cancer Alliance Expert Advisory Groups
National Institute for Health Research North East and North Cumbria (NIHR NENC)
Dr Ashraf Azzabi does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Dr Ashraf Azzabi does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Dr Ashraf Azzabi does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or